Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionClarius Group, LLC
Latest Disclosed Ownership7,988 shares
Latest Disclosed Value $ 2,614,552
Clarius Group, LLC reports 9.30% decrease in ownership of AMGN / Amgen Inc.

On January 14, 2026 - Clarius Group, LLC filed a 13F-HR form disclosing ownership of 7,988 shares of Amgen Inc. (MX:AMGN) valued at $2,614,552 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 14, 2025 disclosing 8,807 shares of Amgen Inc.. This represents a change in shares of -9.30% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-14 2025-12-31 13F AMGEN COM 031162100 7,988 -819 -9.30 2,615 5.19 0.1493
2025-10-14 2025-09-30 13F AMGEN COM 031162100 8,807 -1,405 -13.76 2,485 -12.84 0.1471
2025-07-22 2025-06-30 13F AMGEN COM 031162100 10,212 -65 -0.63 2,851 -10.93 0.1662
2025-04-18 2025-03-31 13F AMGEN COM 031162100 10,277 1,970 23.71 3,202 47.85 0.2011
2025-01-16 2024-12-31 13F AMGEN COM 031162100 8,307 27 0.33 2,165 -18.70 0.1479
2024-10-09 2024-09-30 13F AMGEN COM 031162100 8,280 -131 -1.56 2,663 1.33 0.1868
2024-07-11 2024-06-30 13F AMGEN COM 031162100 8,411 -229 -2.65 2,628 7.00 0.1863
2024-04-17 2024-03-31 13F AMGEN COM 031162100 8,640 -1,178 -12.00 2,457 -13.12 0.1696
2024-01-29 2023-12-31 13F AMGEN COM 031162100 9,818 2,913 42.19 2,828 52.40 0.2345
2023-10-19 2023-09-30 13F AMGEN COM 031162100 6,905 -916 -11.71 1,856 6.85 0.1769
2023-08-10 2023-06-30 13F AMGEN COM 031162100 7,821 303 4.03 1,736 -4.46 0.1342
2023-04-17 2023-03-31 13F AMGEN COM 031162100 7,518 -209 -2.70 1,817 90,750.00 0.1543
2023-01-25 2022-12-31 13F AMGEN COM 031162100 7,727 143 1.89 2 -99.88 0.1827
2022-10-24 2022-09-30 13F AMGEN COM 031162100 7,584 187 2.53 1,709 -5.06 0.1708
2022-08-10 2022-06-30 13F AMGEN COM 031162100 7,397 328 4.64 1,800 13.21 0.1796
2022-04-08 2022-03-31 13F AMGEN COM 031162100 7,069 0 0.00 1,590 0.00 0.1258
2022-02-02 2021-12-31 13F AMGEN COM 031162100 7,069 131 1.89 1,590 7.80 0.1258
2021-10-18 2021-09-30 13F AMGEN COM 031162100 6,938 -356 -4.88 1,475 -17.04 0.1321
2021-08-06 2021-06-30 13F AMGEN COM 031162100 7,294 4 0.05 1,778 -1.98 0.1596
2021-04-27 2021-03-31 13F AMGEN COM 031162100 7,290 454 6.64 1,814 15.39 0.1777
2021-01-15 2020-12-31 13F AMGEN COM 031162100 6,836 599 9.60 1,572 -0.82 0.1694
2020-10-09 2020-09-30 13F AMGEN COM 031162100 6,237 36 0.58 1,585 8.34 0.2036
2020-07-08 2020-06-30 13F AMGEN COM 031162100 6,201 748 13.72 1,463 32.40 0.2050
2020-04-24 2020-03-31 13F AMGEN COM 031162100 5,453 -162 -2.89 1,105 -18.57 0.2084
2020-01-22 2019-12-31 13F AMGEN COM 031162100 5,615 268 5.01 1,357 31.11 0.2149
2019-10-22 2019-09-30 13F AMGEN COM 031162100 5,347 1,095 25.75 1,035 32.02 0.1899
2019-08-02 2019-06-30 13F AMGEN COM 031162100 4,252 322 8.19 784 4.95 0.1577
2019-05-14 2019-03-31 13F AMGEN COM 031162100 3,930 979 33.18 747 30.14 0.1817
2019-02-09 2018-12-31 13F AMGEN COM 031162100 2,951 480 19.43 574 12.11 0.2085
2018-11-13 2018-09-30 13F AMGEN COM 031162100 2,471 1,213 96.42 512 120.69 0.1814
2018-08-06 2018-06-30 13F AMGEN COM 031162100 1,258 0 0.00 232 8.41 0.0963
2018-05-14 2018-03-31 13F AMGEN COM 031162100 1,258 0 0.00 214 -2.28 0.0976
2018-02-09 2017-12-31 13F AMGEN COM 031162100 1,258 0 0.00 219 -6.81 0.0978
2017-11-07 2017-09-30 13F AMGEN COM 031162100 1,258 -1,103 -46.72 235 -42.26 0.0989
2017-08-11 2017-06-30 13F AMGEN COM 031162100 2,361 87 3.83 407 9.12 0.1677
2017-05-04 2017-03-31 13F AMGEN COM 031162100 2,274 0 0.00 373 12.01 0.1540
2017-02-14 2016-12-31 13F/A-1 AMGEN COM 031162100 2,274 -305 -11.83 333 -22.74 0.1408
2017-02-07 2016-12-31 13F AMGEN COM 031162100 1,862 333
2016-11-14 2016-09-30 13F AMGEN COM 031162100 2,579 1 0.04 431 9.95 0.2010
2016-08-12 2016-06-30 13F AMGEN COM 031162100 2,578 -133 -4.91 392 -3.21 0.2089
2016-05-10 2016-03-31 13F AMGEN COM 031162100 2,711 133 5.16 405 -3.11 0.2245
2016-05-10 2015-12-31 13F/A-1 AMGEN COM 031162100 2,578 2,578 418 0.2423
2016-02-16 2015-12-31 13F AMGEN COM 031162100 1,258 204
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.